26 min listen
Unavailable
ratings:
Length:
81 minutes
Released:
Mar 7, 2019
Format:
Podcast episode
Description
[WARNING: This Episode is Long] In recent weeks, Tesla has released a flood of news onto the public markets, from confusion surrounding deliveries in Europe and Asia, departures of multiple C-level executives, contempt charges against Elon Musk by the SEC, price cuts across its entire lineup of vehicles, eliminating the vast majority of its retail presence, and an upcoming announcement of the Model Y-- and that’s the short list. Motley Fool Senior Auto Analyst John Rosevear and Industry Focus Host Nick Sciple discuss these stories and more in a comprehensive look at the challenges facing Tesla today. Listening Guide First ~30 minutes -- $35k Model 3 + Store Closure Announcements + Model Y Middle ~30 minutes -- Import issues in Asia/Europe + Elon’s Contempt of Court Final ~30 minutes -- Consumer Reports Removes Model 3 Rec + Changes to Autopilot Marketing Stocks Mentioned: TSLA Stories Mentioned: Will the Feds Tell Tesla to Fire Elon Musk Over Tweets? Tesla customers describe maddening problems with returns and refunds Tesla doesn’t know where it will build the Model Y as it rolls out more layoffs and cost cuts Former Tesla Workers Paint Grim Picture of Buffalo Plant Elon Musk Should Be Enabled to Step Back From Tesla, Investor Says Tesla ends contract to prepare Model 3 for delivery in Europe a week after first ship NHTSA's Autopilot Claim That Tesla Touted Disputed in New Study Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter
Released:
Mar 7, 2019
Format:
Podcast episode
Titles in the series (100)
Healthcare: Will Vaping Deaths Derail Marijuana Stocks? Plus, A New Treatment for Peanut Allergies Advances: A wave of vaping related illnesses has resulted in at least seven deaths. Here's what people should know about vaping health risks and the potential impact on cannabis companies. Also, Aimmune Therapeutics peanut allergy pill clears an important... by Industry Focus